JP2015513527A5 - - Google Patents

Download PDF

Info

Publication number
JP2015513527A5
JP2015513527A5 JP2014556692A JP2014556692A JP2015513527A5 JP 2015513527 A5 JP2015513527 A5 JP 2015513527A5 JP 2014556692 A JP2014556692 A JP 2014556692A JP 2014556692 A JP2014556692 A JP 2014556692A JP 2015513527 A5 JP2015513527 A5 JP 2015513527A5
Authority
JP
Japan
Prior art keywords
protein
peptide
amino acid
acid sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014556692A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015513527A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/025213 external-priority patent/WO2013119863A1/en
Publication of JP2015513527A publication Critical patent/JP2015513527A/ja
Publication of JP2015513527A5 publication Critical patent/JP2015513527A5/ja
Pending legal-status Critical Current

Links

JP2014556692A 2012-02-07 2013-02-07 オオアワガエリアレルゲン並びに免疫応答モジュレーションのための方法及び使用 Pending JP2015513527A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261596156P 2012-02-07 2012-02-07
US61/596,156 2012-02-07
US201261734886P 2012-12-07 2012-12-07
US61/734,886 2012-12-07
PCT/US2013/025213 WO2013119863A1 (en) 2012-02-07 2013-02-07 Timothy grass allergens and methods and uses for immune response modulation

Publications (2)

Publication Number Publication Date
JP2015513527A JP2015513527A (ja) 2015-05-14
JP2015513527A5 true JP2015513527A5 (https=) 2016-03-24

Family

ID=48948025

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014556692A Pending JP2015513527A (ja) 2012-02-07 2013-02-07 オオアワガエリアレルゲン並びに免疫応答モジュレーションのための方法及び使用

Country Status (13)

Country Link
US (1) US10428124B2 (https=)
EP (1) EP2812026A4 (https=)
JP (1) JP2015513527A (https=)
KR (1) KR20140129124A (https=)
CN (1) CN104203277A (https=)
AU (1) AU2013216993C1 (https=)
BR (1) BR112014019504A2 (https=)
CA (1) CA2864084A1 (https=)
EA (1) EA201491481A1 (https=)
HK (1) HK1204929A1 (https=)
IN (1) IN2014MN01513A (https=)
MX (1) MX2014009285A (https=)
WO (1) WO2013119863A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015054217A2 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for reducing an allergic response in a subject
WO2015054231A1 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for identifying responders to allergy therapy
WO2015077442A2 (en) 2013-11-20 2015-05-28 La Jolla Institute For Allergy And Immunology Grass pollen immunogens and methods and uses for immune response modulation
AU2014352986A1 (en) 2013-11-20 2016-06-16 Alk-Abello A/S Pan pollen immunogens and methods and uses thereof for immune response modulation
BR112016011930A2 (pt) 2013-12-23 2017-09-26 Alk Abello As combinações de peptídeos e seus usos em tratamento de alergia de ácaro de poeira
WO2015131053A1 (en) 2014-02-28 2015-09-03 Alk-Abelló A/S Polypeptides derived from phl p and methods and uses thereof for immune response modulation
EP3925968A3 (en) 2014-10-07 2022-03-02 Cytlimic Inc. Hsp70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
CN113388021A (zh) 2015-03-09 2021-09-14 Cytlimic公司 源于gpc3的肽、使用其的医药组合物、免疫诱导剂、及抗原呈递细胞的制造方法
RU2709015C2 (ru) 2015-04-07 2019-12-13 Ситлимик Инк. Лекарственное средство
CA3023092A1 (en) * 2016-05-03 2017-11-09 Sqz Biotechnologies Company Intracellular delivery of biomolecules to induce tolerance
US11291718B2 (en) 2016-10-11 2022-04-05 Cytlimic Inc. Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
CN119086940A (zh) * 2017-04-28 2024-12-06 朋友股份有限公司 变态反应的抗原及其表位
JP7770314B2 (ja) * 2019-11-25 2025-11-14 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 診断及び処置のための抗原ニューロン特異的エノラーゼペプチド
CN120349374B (zh) * 2025-03-25 2025-10-10 长沙理工大学 一种米渣短肽及其在降尿酸中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
AUPR775401A0 (en) * 2001-09-18 2001-10-11 Monash University Novel Epitopes and Uses Thereof
EP2392591B1 (de) * 2002-06-25 2018-02-21 Merck Patent GmbH DNA-Sequenz und rekombinante Herstellung des Graspollen-Allergens Phl p 4
RU2323942C2 (ru) 2002-08-19 2008-05-10 Мерк Патент Гмбх ВАРИАНТЫ ОСНОВНОГО АЛЛЕРГЕНА Phl p 1 ИЗ ТИМОФЕЕВКИ ЛУГОВОЙ
WO2004047793A1 (en) * 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
AU2006204997B2 (en) 2005-01-12 2011-09-01 Monsanto Technology, Llc Genes and uses for plant improvement
US20090070897A1 (en) * 2006-01-12 2009-03-12 Goldman Barry S Genes and uses for plant improvement
PL2244734T3 (pl) * 2008-02-01 2017-01-31 Murdoch Childrens Research Institute Sposób indukcji tolerancji na alergen
EP2388268A1 (en) * 2010-05-18 2011-11-23 Stallergenes S.A. Recombinant Der p 2 expressed in Pichia pastoris as a "natural-like" allergen for immunotherapy and diagnostic purposes
US20120100163A1 (en) 2010-10-15 2012-04-26 Alk-Abello A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
US20120100164A1 (en) 2010-10-15 2012-04-26 Alk-Abello A/S Suppression of a hypersensitivity immune response with unrelated antigen derived from allergen source material
US9700071B2 (en) * 2012-03-26 2017-07-11 Axcella Health Inc. Nutritive fragments, proteins and methods
JP2015514126A (ja) 2012-04-16 2015-05-18 アルク−アベッロ エイ/エスAlk−Abello A/S 非特異的アレルギー免疫療法において使用するための植物プロフィリンポリペプチド

Similar Documents

Publication Publication Date Title
JP2015513527A5 (https=)
JP2016222689A5 (ja) 合成ペプチド及び乾燥粉末薬剤輸送システム
NZ621868A (en) Growth hormone polypeptides and methods of making and using same
HRP20220717T1 (hr) Modificirani pripravci mrna
HRP20192314T1 (hr) Pripravci faktora viii i postupci pripreme i njihove uporabe
JP2015514395A5 (https=)
WO2014207708A3 (en) Amino acid and peptide conjugates and conjugation process
NZ733168A (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
HRP20240226T1 (hr) Pripravci cjepiva koji sadrže protein vezivanja mutiranog faktora h
RU2017104529A (ru) Композиции neisseria meningitidis и способы их применения
JP2017048194A5 (https=)
BRPI0910461B8 (pt) hormônio de estimulação do folículo recombinante, sua composição farmacêutica, seu método de produção e seu uso
HRP20161608T1 (hr) Modificirani tuberkulozni antigeni
EP3363458A3 (en) A peptide
HRP20190982T1 (hr) Peptidi i njihova uporaba
RU2015138530A (ru) Комбинированная вакцина против респираторно-синцитиального вируса и вируса гриппа
EA201591213A1 (ru) Вакцины против вируса гепатита b
JP2014058541A5 (https=)
FI3065763T4 (fi) Il-22-dimeerin käyttö lääkkeen valmistamisessa suonensisäistä antoa varten
WO2017145097A3 (en) Amino acid and peptide conjugates and conjugation process
RU2016107873A (ru) Пептиды
WO2013021284A3 (en) Anti-il-6 vaccine composition
JP2016520534A5 (https=)
RU2019113989A (ru) Лекарственное средство
JP2016515123A5 (https=)